PARTNERSHIPS
13 Jan 2026
INVESTMENT
12 Jan 2026
TECHNOLOGY
7 Jan 2026
RESEARCH
19 Dec 2025

REGULATORY
18 Dec 2025
HHS is winding down BARDA-backed mRNA vaccine programs, prompting analysts to see a shift toward commercially focused mRNA strategies

RESEARCH
14 Aug 2025
Strand's STX-001 shows early tumor-fighting promise as mRNA shifts from vaccines to therapeutics.

INVESTMENT
9 Aug 2025
Boston biotech secures major funding as investors back oncology applications of mRNA

INSIGHTS
6 Aug 2025
Acuitas pioneers gene-editing delivery for rare disease, signaling mRNA's evolution beyond vaccines.

TECHNOLOGY
29 Jul 2025
UT Austin and Sanofi unveil RiboNN, an Al that speeds mRNA drug development and raises early-stage success rates.

INNOVATION
25 Jul 2025
Orbital's circular RNA reprograms CAR-T cells in vivo, cutting costs and widening access for autoimmune and cancer care.

REGULATORY
27 Jun 2025
New FDA rules force Moderna and Pfizer to add clearer heart warnings to mRNA vaccine labels.
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.